HALO
Halozyme Therapeutics Inc
NASDAQ: HALO · HEALTHCARE · BIOTECHNOLOGY
$63.06
-1.25% today
Updated 2026-04-29
Market cap
$7.47B
P/E ratio
24.63
P/S ratio
5.35x
EPS (TTM)
$2.56
Dividend yield
—
52W range
$48 – $82
Volume
1.6M
Halozyme Therapeutics Inc (HALO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $20.51M | $46.09M | $103.46M | $76.56M | $77.15M | $91.35M | $65.76M | $134.73M | $101.79M | $165.98M | $181.79M | $261.51M | $519.95M | $440.25M | $565.87M | $579.92M | $1.10B | $1.84B | $1.73B | $2.06B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $20.11M | $45.59M | $101.18M | $74.01M | $74.44M | $89.50M | $63.99M | $131.03M | $95.20M | $161.32M | $171.77M | $256.53M | $510.37M | $427.85M | $543.44M | $554.76M | $926.29M | $739.01M | $746.42M | $1.09B |
| Total liabilities | $2.30M | $23.01M | $45.69M | $61.18M | $70.25M | $70.99M | $54.86M | $85.87M | $121.78M | $124.63M | $138.79M | $294.00M | $311.58M | $191.36M | $474.11M | $428.88M | $907.48M | $1.67B | $1.65B | $1.70B |
| Current liabilities | $2.30M | $4.25M | $8.86M | $14.22M | $14.40M | $15.34M | $17.30M | $18.95M | $25.45M | $24.33M | $62.46M | $54.59M | $131.33M | $149.36M | $85.64M | $421.38M | $117.15M | $130.79M | $112.49M | $139.10M |
| Long-term debt | — | — | — | — | — | — | $0.00 | $29.66M | $49.77M | $49.86M | $27.97M | $199.23M | $125.14M | $34.87M | $383.05M | — | $787.25M | $1.49B | $1.50B | $1.51B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-26.35M | $-41.10M | $-65.00M | $-113.65M | $-172.01M | $-225.25M | $-245.02M | $-298.57M | $-382.05M | $-450.43M | $-482.66M | $-585.34M | $-522.37M | $-531.44M | $-603.68M | $-474.59M | $-58.91M | $143.22M | $90.55M | $359.87M |
| Accounts receivable | $413829.00 | $533387.00 | $779825.00 | $7.26M | $4.24M | $2.33M | $2.26M | $15.70M | $9.10M | $9.15M | $32.41M | $15.68M | $22.13M | $30.00M | $59.44M | $97.73M | $90.97M | $231.07M | $234.21M | $308.45M |
| Inventory | $278958.00 | $442492.00 | $703468.00 | $441323.00 | $1.16M | $193422.00 | $567263.00 | $2.67M | $6.17M | $6.41M | $9.49M | $14.62M | $5.15M | $22.63M | $29.36M | $60.75M | $53.91M | $100.12M | $127.60M | $141.86M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $0.00 | $409.05M | $416.82M | $416.82M |